Molecular Testing of Lymphoproliferative Disorders: Current Status and Perspectives

Molecular pathologic testing plays an important role for the diagnosis, prognostication and decision of treatment strategy in lymphoproliferative disease. Here, we briefly review the molecular tests currently used for lymphoproliferative disease and those which will be implicated in clinical practic...

Full description

Bibliographic Details
Main Authors: Yoon Kyung Jeon, Sun Och Yoon, Jin Ho Paik, Young A Kim, Bong Kyung Shin, Hyun-Jung Kim, Hee Jeong Cha, Ji Eun Kim, Jooryung Huh, Young-Hyeh Ko
Format: Article
Language:English
Published: Korean Society of Pathologists & the Korean Society for Cytopathology 2017-05-01
Series:Journal of Pathology and Translational Medicine
Subjects:
Online Access:http://www.jpatholtm.org/upload/pdf/jptm-2017-04-09.pdf
_version_ 1828239872728498176
author Yoon Kyung Jeon
Sun Och Yoon
Jin Ho Paik
Young A Kim
Bong Kyung Shin
Hyun-Jung Kim
Hee Jeong Cha
Ji Eun Kim
Jooryung Huh
Young-Hyeh Ko
author_facet Yoon Kyung Jeon
Sun Och Yoon
Jin Ho Paik
Young A Kim
Bong Kyung Shin
Hyun-Jung Kim
Hee Jeong Cha
Ji Eun Kim
Jooryung Huh
Young-Hyeh Ko
author_sort Yoon Kyung Jeon
collection DOAJ
description Molecular pathologic testing plays an important role for the diagnosis, prognostication and decision of treatment strategy in lymphoproliferative disease. Here, we briefly review the molecular tests currently used for lymphoproliferative disease and those which will be implicated in clinical practice in the near future. Specifically, this guideline addresses the clonality test for B- and T-cell proliferative lesions, molecular cytogenetic tests for malignant lymphoma, determination of cell-of-origin in diffuse large B-cell lymphoma, and molecular genetic alterations incorporated in the 2016 revision of the World Health Organization classification of lymphoid neoplasms. Finally, a new perspective on the next-generation sequencing for diagnostic, prognostic, and therapeutic purpose in malignant lymphoma will be summarized.
first_indexed 2024-04-12T21:30:01Z
format Article
id doaj.art-4c49acbab7d740dfb6d25febeef70f9e
institution Directory Open Access Journal
issn 2383-7837
2383-7845
language English
last_indexed 2024-04-12T21:30:01Z
publishDate 2017-05-01
publisher Korean Society of Pathologists & the Korean Society for Cytopathology
record_format Article
series Journal of Pathology and Translational Medicine
spelling doaj.art-4c49acbab7d740dfb6d25febeef70f9e2022-12-22T03:16:03ZengKorean Society of Pathologists & the Korean Society for CytopathologyJournal of Pathology and Translational Medicine2383-78372383-78452017-05-0151322424110.4132/jptm.2017.04.0916689Molecular Testing of Lymphoproliferative Disorders: Current Status and PerspectivesYoon Kyung JeonSun Och Yoon0Jin Ho Paik1Young A Kim2Bong Kyung Shin3Hyun-Jung Kim4Hee Jeong Cha5Ji Eun Kim6Jooryung Huh7Young-Hyeh Ko8 Department of Pathology, Yonsei University College of Medicine, Seoul, Korea Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea Department of Pathology, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea Department of Pathology, Korea University Guro Hospital, Korea University School of Medicine, Seoul, Korea Department of Pathology, Inje University Sanggye Paik Hospital, Seoul, Korea Department of Pathology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea Department of Pathology, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, KoreaMolecular pathologic testing plays an important role for the diagnosis, prognostication and decision of treatment strategy in lymphoproliferative disease. Here, we briefly review the molecular tests currently used for lymphoproliferative disease and those which will be implicated in clinical practice in the near future. Specifically, this guideline addresses the clonality test for B- and T-cell proliferative lesions, molecular cytogenetic tests for malignant lymphoma, determination of cell-of-origin in diffuse large B-cell lymphoma, and molecular genetic alterations incorporated in the 2016 revision of the World Health Organization classification of lymphoid neoplasms. Finally, a new perspective on the next-generation sequencing for diagnostic, prognostic, and therapeutic purpose in malignant lymphoma will be summarized.http://www.jpatholtm.org/upload/pdf/jptm-2017-04-09.pdfLymphoproliferative disordersMalignant lymphomaPathology, molecularMolecular diagnosticsClonality testGene translocationin situ hybridization, fluorescenceNext-generation sequencing
spellingShingle Yoon Kyung Jeon
Sun Och Yoon
Jin Ho Paik
Young A Kim
Bong Kyung Shin
Hyun-Jung Kim
Hee Jeong Cha
Ji Eun Kim
Jooryung Huh
Young-Hyeh Ko
Molecular Testing of Lymphoproliferative Disorders: Current Status and Perspectives
Journal of Pathology and Translational Medicine
Lymphoproliferative disorders
Malignant lymphoma
Pathology, molecular
Molecular diagnostics
Clonality test
Gene translocation
in situ hybridization, fluorescence
Next-generation sequencing
title Molecular Testing of Lymphoproliferative Disorders: Current Status and Perspectives
title_full Molecular Testing of Lymphoproliferative Disorders: Current Status and Perspectives
title_fullStr Molecular Testing of Lymphoproliferative Disorders: Current Status and Perspectives
title_full_unstemmed Molecular Testing of Lymphoproliferative Disorders: Current Status and Perspectives
title_short Molecular Testing of Lymphoproliferative Disorders: Current Status and Perspectives
title_sort molecular testing of lymphoproliferative disorders current status and perspectives
topic Lymphoproliferative disorders
Malignant lymphoma
Pathology, molecular
Molecular diagnostics
Clonality test
Gene translocation
in situ hybridization, fluorescence
Next-generation sequencing
url http://www.jpatholtm.org/upload/pdf/jptm-2017-04-09.pdf
work_keys_str_mv AT yoonkyungjeon moleculartestingoflymphoproliferativedisorderscurrentstatusandperspectives
AT sunochyoon moleculartestingoflymphoproliferativedisorderscurrentstatusandperspectives
AT jinhopaik moleculartestingoflymphoproliferativedisorderscurrentstatusandperspectives
AT youngakim moleculartestingoflymphoproliferativedisorderscurrentstatusandperspectives
AT bongkyungshin moleculartestingoflymphoproliferativedisorderscurrentstatusandperspectives
AT hyunjungkim moleculartestingoflymphoproliferativedisorderscurrentstatusandperspectives
AT heejeongcha moleculartestingoflymphoproliferativedisorderscurrentstatusandperspectives
AT jieunkim moleculartestingoflymphoproliferativedisorderscurrentstatusandperspectives
AT jooryunghuh moleculartestingoflymphoproliferativedisorderscurrentstatusandperspectives
AT younghyehko moleculartestingoflymphoproliferativedisorderscurrentstatusandperspectives